These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 9038357)
1. Potent inhibition of inducible nitric oxide synthase by geldanamycin, a tyrosine kinase inhibitor, in endothelial, smooth muscle cells, and in rat aorta. Joly GA; Ayres M; Kilbourn RG FEBS Lett; 1997 Feb; 403(1):40-4. PubMed ID: 9038357 [TBL] [Abstract][Full Text] [Related]
2. Tyrosine kinase inhibitors suppress endotoxin- and IL-1 beta-induced NO synthesis in aortic smooth muscle cells. Marczin N; Papapetropoulos A; Catravas JD Am J Physiol; 1993 Sep; 265(3 Pt 2):H1014-8. PubMed ID: 8214107 [TBL] [Abstract][Full Text] [Related]
3. Possible involvement of tyrosine kinase in the LPS-promoted initiation of L-arginine-induced relaxation of rat aorta mediated by induction of no synthase. Moritoki H; Hisayama T; Takeuchi S; Kondoh W; Takeji Y Life Sci; 1995; 57(11):PL125-30. PubMed ID: 7544862 [TBL] [Abstract][Full Text] [Related]
4. Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human islets. Corbett JA; Kwon G; Marino MH; Rodi CP; Sullivan PM; Turk J; McDaniel ML Am J Physiol; 1996 Jun; 270(6 Pt 1):C1581-7. PubMed ID: 8764139 [TBL] [Abstract][Full Text] [Related]
6. Effect of tyrosine kinase and tyrosine phosphatase inhibitors on aortic contraction and induction of nitric oxide synthase. Duarte J; Ocete MA; Pérez-Vizcaino F; Zarzuelo A; Tamargo J Eur J Pharmacol; 1997 Oct; 338(1):25-33. PubMed ID: 9408000 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta. Joly GA; Narayanan K; Griffith OW; Kilbourn RG Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform. Szabó C; Bryk R; Zingarelli B; Southan GJ; Gahman TC; Bhat V; Salzman AL; Wolff DJ Br J Pharmacol; 1996 Aug; 118(7):1659-68. PubMed ID: 8842429 [TBL] [Abstract][Full Text] [Related]
9. Protein tyrosine kinase inhibitors decrease induction of nitric oxide synthase activity in lipopolysaccharide-responsive and lipopolysaccharide-nonresponsive murine macrophages. Dong Z; Qi X; Xie K; Fidler IJ J Immunol; 1993 Sep; 151(5):2717-24. PubMed ID: 7689614 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896 [TBL] [Abstract][Full Text] [Related]
11. Involvement of a tyrosine kinase pathway in the growth-promoting effects of angiotensin II on aortic smooth muscle cells. Leduc I; Haddad P; Giasson E; Meloche S Mol Pharmacol; 1995 Oct; 48(4):582-92. PubMed ID: 7476882 [TBL] [Abstract][Full Text] [Related]
12. Regulation of the nitric oxide synthase-nitric oxide-cGMP pathway in rat mesenteric endothelial cells. Papapetropoulos A; Andreopoulos S; Go CY; Hoque A; Fuchs LC; Catravas JD J Appl Physiol (1985); 2001 Dec; 91(6):2553-60. PubMed ID: 11717218 [TBL] [Abstract][Full Text] [Related]
13. Induction of L-arginine transport and nitric oxide synthase in vascular smooth muscle cells: synergistic actions of pro-inflammatory cytokines and bacterial lipopolysaccharide. Wileman SM; Mann GE; Baydoun AR Br J Pharmacol; 1995 Dec; 116(8):3243-50. PubMed ID: 8719803 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of tyrosine kinase inhibitors on tumor necrosis factor and nitric oxide production by murine macrophages. Orlicek SL; Meals E; English BK J Infect Dis; 1996 Sep; 174(3):638-42. PubMed ID: 8769628 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of inducible nitric oxide synthase by beta-lapachone in rat alveolar macrophages and aorta. Liu SH; Tzeng HP; Kuo ML; Lin-Shiau SY Br J Pharmacol; 1999 Feb; 126(3):746-50. PubMed ID: 10188987 [TBL] [Abstract][Full Text] [Related]
16. Effects of tyrphostins and genistein on the circulatory failure and organ dysfunction caused by endotoxin in the rat: a possible role for protein tyrosine kinase. Ruetten H; Thiemermann C Br J Pharmacol; 1997 Sep; 122(1):59-70. PubMed ID: 9298529 [TBL] [Abstract][Full Text] [Related]
17. Nifedipine inhibits the induction of nitric oxide synthase by bacterial lipopolysaccharide. Szabó C; Mitchell JA; Gross SS; Thiemermann C; Vane JR J Pharmacol Exp Ther; 1993 May; 265(2):674-80. PubMed ID: 7684445 [TBL] [Abstract][Full Text] [Related]
18. Tyrosine kinase activation is necessary for inducible nitric oxide synthase expression by interleukin-1 beta. Tetsuka T; Morrison AR Am J Physiol; 1995 Jul; 269(1 Pt 1):C55-9. PubMed ID: 7543244 [TBL] [Abstract][Full Text] [Related]
19. Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages. Kengatharan M; De Kimpe SJ; Thiemermann C Br J Pharmacol; 1996 Mar; 117(6):1163-70. PubMed ID: 8882611 [TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitors, genistein and herbimycin A, do not block interleukin-1 beta-induced activation of NF-kappa B in rat mesangial cells. Tetsuka T; Srivastava SK; Morrison AR Biochem Biophys Res Commun; 1996 Jan; 218(3):808-12. PubMed ID: 8579596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]